CD274 and metastatic neoplasm: Although pathological diagnosis is the gold standard to evaluate PD-L1 levels, it is impossible to repeatedly examine biopsies of multiple lesions, and there is a need to develop non-invasive methods to assess PD-L1 levels in recurrent and metastatic disease.